Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05906147

Health ImprOvement Program of Bone in China

Fracture risk factors have long been identified as key factors in osteoporosis and fragility fractures. The WHO recommended Fracture risk assessmenttool (FRAX) applies clinical risk factors to assess the absolute risk of osteoporotic fractures in each individual. Our preliminary study suggests that FRAX estimates may underestimate the risk of fractures in the Chinese population. In order to optimize the risk prediction model of osteoporotic fractures, a treatment threshold and its optimal cutting point were initially established based on the data of the health management Center of the Second Xiangya Hospital of Central South University.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Osteoporosis Bone Diseases Bone Diseases, Metabolic Metabolic Diseases Musculoskeletal Diseases Nutritional and Metabolic Diseases

Age range

40 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Health Management Center, The Second Xiangya Hospital of Central South University

Changsha, Hunan, 410000, China

Location status: Recruiting

Location contact

zhifeng sheng, doctorate

CONTACT

[email protected]

008613574806523

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Dual-energy X-ray bone mineral density measurement was performed in the health management center of our hospital in the physical examination subjects over 40 years old. Have independent civil capacity and agree to participate, and sign informed consent

Exclusion criteria

  • Under 40 years of age， Patients who had undergone hip replacement or lumbar surgery and could not perform dual-energy X-ray BMD testing; Patients who have been treated with effective anti-osteoporosis drugs or have a history of malignant tumors.

Treatment and study plan

Regular follow-up

Other

Follow-up of the population was conducted to track the incidence of fractures

Primary outcomes

  1. bone mineral density bone mineral density

    Time frame: From 2021 to 2031

    Bone mineral density (BMD) data measured by dual-energy X-ray absorptiometry were collected from patients over 40 years old

  2. Occurrence of fracture

    Time frame: From 2021 to 2031

    Follow-up of the population was conducted to track the incidence of fractures

  3. clinical risk factors of osteoporotic fracture

    Time frame: From 2021 to 2031

    The main clinical risk factors of osteoporotic fracture were collected

Study contacts

Contact information is provided by the study sponsor or research team.

chun yue, doctorate

CONTACT

[email protected]

008615700733115

zhifeng sheng, doctorate

CONTACT

[email protected]

008613574806523

Sponsors and collaborators

Lead sponsor

Second Xiangya Hospital of Central South University

Other

Registry information

Important dates

Study start
2021
Primary completion
2021
Study completion
2031
First posted
Jun 15, 2023
Registry last updated
Jun 15, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.